Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2016-04-26
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well choline magnesium trisalicylate with
idarubicin and cytarabine works in treating patients with acute myeloid leukemia. Drugs used
in chemotherapy, such as choline magnesium trisalicylate, idarubicin, and cytarabine, work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing. It is not yet know whether choline magnesium trisalicylate and
combination chemotherapy is more effective than combination chemotherapy alone in treating
patients with acute myeloid leukemia.
Phase:
Phase 2
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborators:
National Cancer Institute (NCI) Rutgers Cancer Institute of New Jersey